Beauty Farm Medical and Health Industry Inc. repurchased 60,000 ordinary shares on 22 June 2026 via the Hong Kong Stock Exchange, paying a total of HKD 1.02 million. The transaction was executed within a price range of HKD 16.87 to HKD 17.16 per share, producing a volume-weighted average cost of HKD 17.04.
Following the buyback, the company’s issued share capital excluding treasury shares declined to 248.63 million from 248.69 million, a reduction of 0.024 %. Treasury shares increased to 2.96 million, while the total share count remained unchanged at 251.59 million.
The repurchase formed part of the mandate authorised on 27 June 2025, which permits the company to buy back up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 2.96 million shares, equivalent to 1.26 % of the issued shares outstanding when the mandate was approved.
Under Hong Kong listing rules, Beauty Farm is subject to a 30-day moratorium—up to 22 July 2026—on issuing new shares or transferring treasury shares following this buyback.
Comments